Dow Down 1.40% Nasdaq Down 1.59%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
355.61 Down 4.91(1.36%) 4:00PM EDT
|After Hours : 351.16 Down 4.45 (1.25%) 5:31PM EDT - Nasdaq Real Time Price
Prev Close:360.52
Open:363.95
Bid:352.18 x 200
Ask:355.25 x 100
1y Target Est:369.47
Beta:0.65
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:352.91 - 363.95
52wk Range:257.69 - 369.31
Volume:667,607
Avg Vol (3m):791,798
Market Cap:35.70B
P/E (ttm):101.20
EPS (ttm):3.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
REGNDown 1.36%35.70B
AMGNDown 1.17%105.45B
NVSDown 0.97%226.17B
RHHBYDown 0.68%249.64B

Key Statistics

Forward P/E (1 yr):28.82
P/S (ttm):14.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.12
Quarterly EPS Est (Sep-14) :2.57
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback